Direct costs of multiple high dose chemotherapy (HDC) and autologous blood stem cell transplantation (ABSCT) in high risk breast cancer patients (pts):: The EIO experience.

被引：0
|
作者：
Scalamogna, R [1 ]
Vaccari, D [1 ]
Ferrari, L [1 ]
Cocquio, A [1 ]
Salè, EO [1 ]
Peccatori, F [1 ]
Cinieri, S [1 ]
Goldhirsch, A [1 ]
Martinelli, G [1 ]
机构：
[1] European Inst Oncol, Div Hematoncol, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
66P
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [1] Prolonged clinical remission in patients (pts) with inflammatory bowel disease (IBD) after high dose chemotherapy (HDC) and autologous blood stem cell transplantation (ABSCT).
    Castro, J
    Bentch, HL
    Smith, L
    Kalter, S
    Bachier, C
    Meneghetti, C
    Moore, A
    Oliversen, S
    LeMaistre, CF
    BLOOD, 1996, 88 (10) : 519 - 519
  • [2] High dose chemotherapy (HDC) and autologous stem cell transplantation (SCT) for breast cancer (BC) patients above the age of 55.: A single institution experience.
    Rondón, G
    Montemurro, F
    Ueno, N
    Giralt, S
    Andersson, B
    Anderlini, P
    Donato, M
    Khouri, I
    Claxton, D
    Gajewski, J
    Champlin, R
    BLOOD, 1999, 94 (10) : 405B - 405B
  • [3] High dose chemotherapy (HDC) with peripheral blood stem cell (PBSC) transplantation for patients (pts) with advanced ovarian cancer.
    Bojko, P
    Hilger, R
    Schenlen, ME
    Oberhoff, C
    Schindler, AE
    Seeber, S
    ANNALS OF ONCOLOGY, 2000, 11 : 82 - 82
  • [4] High-dose chemotherapy (HDC) and autologous stem cell transplant for breast cancer patients.
    Martino, M
    Console, G
    Irrera, G
    Messina, G
    Pucci, G
    Ramirez, F
    Oliva, B
    Palazzo, S
    Gasparini, G
    Morabito, F
    Iacopino, P
    BONE MARROW TRANSPLANTATION, 1999, 23 : S41 - S41
  • [5] High dose chemotherapy (HDC) with stem cell transplantation (PBSCT) for lymphoma.: A single institution experience.
    Cajal, R
    Varo, MJ
    Mayordomo, JI
    Palomera, L
    Yubero, A
    Moreno, JA
    Isla, MD
    Herraez, J
    Bueso, P
    Marti, JL
    Murillo, L
    Sáenz, A
    Escudero, P
    Garcia, MD
    Gutierrez, M
    Tres, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S89 - S89
  • [6] High-dose chemotherapy (HDC) & autologous PBPC transplantation in the adjuvant treatment of high risk breast cancer
    Constenla, M
    Lorenzo, I
    Rey, C
    Carrete, N
    Campos, B
    Arroyo, FR
    Ozores, R
    BONE MARROW TRANSPLANTATION, 1999, 23 : S38 - S38
  • [7] Clinical outcome of germ cell cancer patients (pts) treated with high-dose chemotherapy with stem cell support (HDC) - a single center experience.
    Dos Santos, EG
    Leal-Da-costa, F
    Miranda, N
    Machado, A
    Guimaraes, A
    Ferreira, I
    Abecasis, M
    Passos-Coelho, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 437S - 437S
  • [8] Triple (T) high-dose chemotherapy (HDC) with autologous blood stem cell rescue (ABSR) is not superior to double (D) HDC with ABSR in patients (pts) with metastatic breast cancer (MBC).
    Schneeweiss, A
    Görner, R
    Hensel, M
    Egerer, G
    Khbeis, T
    Solomayer, E
    Haas, R
    Grischke, EM
    Ho, A
    Bastert, G
    ANNALS OF ONCOLOGY, 2000, 11 : 30 - 31
  • [9] High-dose chemotherapy and autologous stem cell transplantation for breast cancer
    Baynes, RD
    Dansey, RD
    Klein, JL
    Karanes, C
    Cassells, L
    Abella, E
    Wei, WZ
    Galy, A
    Du, W
    Wood, G
    Peters, WP
    CANCER INVESTIGATION, 2000, 18 (05) : 440 - 455
  • [10] High-dose chemotherapy and autologous stem cell transplantation as treatment for high-risk breast cancer
    Martin S. Tallman
    William J. Gradishar
    Cancer Chemotherapy and Pharmacology, 1998, 42 : S60 - S67
12345